Certified in 2005, the cluster assures synergies between its members, distributed into four areas: Small- and medium-sized enterprises, Large companies, Research, Local authorities.

Mission:

To bolster the international competitiveness, visibility and attractiveness of Paris and its region, and to become one of the world leaders in the biomedical innovation field by the year 2012.

A strategy of concentration

Three topics with a THERAPEUTIC FOCUS- neurosciences
- oncology
- infectious pathology

Three topics with a TECHNOLOGICAL FOCUS- biomedical imaging
- cellular and molecular medicine
- pharmaceutical sciences and technology

Advantages

Ile-de-France, leading economic region in Europe in life sciences and health:
• World leaders in the pharmaceutical industry
• 50% of French biotechnology companies
• 9 universities and 20 grandes écoles
• 300 public and private research laboratories

Members

Almost 160 members of the cluster
•    25 organizations for research, higher education and promotion of research to the benefit of companies:
Centre National de la Recherche Scientifique (CNRS), Ecole Centrale de Paris, Ecole Polytechnique, Ecole Normale Supérieure de Cachan, Institut Curie, Institut Pasteur, Université de Cergy-Pontoise, Université de Versailles et Saint-Quentin-en-Yvelines, Université de Paris XII Val-de-Marne etc.

•    16 local councils with their economic development organizations
The General Councils (county councils) of Val-d’Oise, Yvelines, Seine-et-Marne, Seine-Saint-Denis and Essonne, the City of Paris, the Regional Council of Ile-de-France etc.

•    115 companies
Large Companies: 12
French companies: Sanofi-Aventis, Servier, Ipsen, Guerbet etc. 
International companies: GE HealthCare (United States), GlaxoSmithKline (United Kingdom), Phillips Medical System (Netherlands), Siemens Medical Solutions (Germany) etc.
Small- and medium-sized enterprises (SME): 103

Current R&D Project Partnerships

30 projects certified between 2005 and 2008 (refer to appendix) for an overall budget of 107 million euros

43 million euros have been financed through various public subsidies:
•    The Single Interministerial Fund (Fonds Unique Interministériel or FUI) and the subsidies of local Ile-de-France councils
•    The National Research Agency  (Agence Nationale de la Recherche)

International Partnerships

Current:•    Agreement signed with the University of Debrecen, Hungary

Future:•    Agreement in progress with Israeli incubator

Read more